ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

WELLS FARGO & COMPANY/MN's Holding History (CIK: 0000072971)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,428,000 Value ($000) $2,102 Avg Close — Range —
Q3 2025
Shares 943,000 Value ($000) $1,531 Avg Close — Range —
Q2 2025
Shares 710,000 Value ($000) $916 Avg Close — Range —
Q1 2025
Shares 712,000 Value ($000) $822 Avg Close — Range —
Q4 2024
Shares 761,000 Value ($000) $813 Avg Close — Range —
Q3 2024
Shares 3,023,000 Value ($000) $3,536 Avg Close — Range —
Q2 2024
Shares 2,782,000 Value ($000) $3,000 Avg Close — Range —
Q1 2024
Shares 5,806,000 Value ($000) $5,473 Avg Close — Range —
Q4 2023
Shares 7,588,000 Value ($000) $7,494 Avg Close — Range —
Q3 2023
Shares 7,553,000 Value ($000) $7,015 Avg Close — Range —